Cited by 163Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.

Open access

Ip, Stanley, Lichtenstein, Alice H., Chung, Mei, Lau, Joseph, Balk, Ethan M.·2009·Annals of Internal Medicine

DOI 10.7326/0003-4819-150-7-200904070-00007PMC PMC6880859

Open this paper in CoChat — free account

Abstract

BACKGROUND: Measures of low-density lipoprotein (LDL) subfractions have been proposed as an independent risk factor for cardiovascular disease. PURPOSE: To review published studies that reported relationships between LDL subfractions and cardiovascular outcomes. DATA SOURCES: MEDLINE (1950 to 5 January 2009), CAB Abstracts (1973 to 30 June 2008), and Cochrane Central Register of Controlled Trials (2nd quarter of 2008), limited to English-language studies. STUDY SELECTION: 3 reviewers selected longitudinal studies with 10 or more participants that reported an association between LDL subfractions and incidence or severity of cardiovascular disease and in which plasma samples were collected before outcome determination. DATA EXTRACTION: Data were extracted from 24 studies. The 10 studies that used analytical methods available for clinical use (all of which used nuclear magnetic resonance) had full data extraction, including quality assessment (good, fair, or poor). All studies were extracted by 1 researcher and verified by another. DATA SYNTHESIS: All 24 studies, and the subset of 10 nuclear magnetic resonance studies, were heterogeneous in terms of the specific tests analyzed, analytical methods used, participants investigated, and outcomes measured. Higher LDL particle number was consistently associated with increased risk for cardiovascular disease, independent of other lipid measurements. Other LDL subfractions were generally not associated with cardiovascular disease after adjustment for cholesterol concentrations. No study evaluated the incremental value of LDL subfractions beyond traditional cardiovascular risk factors or their test performance. LIMITATION: Publication bias was a possibility. CONCLUSION: Higher LDL particle number has been associated with cardiovascular disease incidence, but studies have not determined whether any measures of LDL subfractions add incremental benefit to traditional risk factor assessment. Routine use of clinically available LDL subfraction tests to estimate cardiovascular disease risk is premature.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-150-7-200904070-00007

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction
Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03540110036029 · Cited by 1,081
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“…case–control 68 70 100 17 63 (ever smoked) LDL-c: 142 mg/dL Mykkänen et al, 1999 (27) GE Nested case–control 69 100 50 33 20 (current) TC–HDL-c ratio: 6.09 Gardner et al, 1996 (26) GE Nested case–control 59 33 73 No data 42 (not defined) Non–HDL-c: 176 mg/dL CAD coronary artery disease; CHD…”
Influential
Lipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M. H., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 716
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors
Chan, A.-W., & Altman, D. G. (2005) · BMJ · doi:10.1136/bmj.38356.424606.8f · Cited by 613 · cited 1×
“It is likely that the positive secondary analyses were more often reported because negative results may be considered uninteresting and are thus less likely to be selected for journal publication or included in articles because of space limitations (38).”
Background
Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
Otvos, J. D., Collins, D. E., Freedman, D. S., SHALAUROVA, I. Y., Schaefer, E. J., McNamara, J. R., Bloomfield, H. E., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.565135 · Cited by 542

Show all 44 references

Research works printed but not linked: 3

Chapman MJ, 1998, Eur Heart J, 19, A24
Zhao XQ, 2003, Med Sci Monit, 9, CR48
Lamarche B, 2001, Can J Cardiol, 17, 859

Sorted by citations

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,976
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,348
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Small Dense Low‐Density Lipoprotein as Biomarker for Atherosclerotic Diseases
Ivanova, E. A., Myasoedova, V. A., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1273042 · Cited by 481
Diabetes and lipid metabolism
Athyros, V. G., Doumas, M. N., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., & Karagiannis, A. I. (2018) · HORMONES · doi:10.1007/s42000-018-0014-8 · Cited by 384
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary
Greenland, P., Alpert, J. S., Beller, G., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051bab · Cited by 353
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
Bruckert, E., Labreuche, J., & Amarenco, P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.023 · Cited by 273
Lipoprotein subfractions and cardiovascular disease risk
Krauss, R. M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b7756 · Cited by 272
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Langlois, M. R., Chapman, M. J., Cobbaert, C., Mora, S., Remaley, A. T., Ros, E., Watts, G. F., Borén, J., Baum, H., Bruckert, E., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287037 · Cited by 260
Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial
Geidl-Flueck, B., Hochuli, M., Németh, Á., Eberl, A., Derron, N., Köfeler, H. C., Tappy, L., Berneis, K., Spinas, G. A., & Gerber, P. A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.027 · Cited by 238
The ketogenic diet: Pros and cons
O'Neill, B., & Raggi, P. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.021 · Cited by 219
Saturated fats and cardiovascular health: Current evidence and controversies
Maki, K. C., Dicklin, M. R., & Kirkpatrick, C. F. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.09.049 · Cited by 233
Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study
Parish, S., Offer, A. R., Clarke, R., Hopewell, J. C., Hill, M., Otvos, J. D., Armitage, J., & Collins, R. (2012) · Circulation · doi:10.1161/circulationaha.111.073684 · Cited by 212
Small dense LDL: An emerging risk factor for cardiovascular disease
Hirayama, S., & Miida, T. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.09.010 · Cited by 209
Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk.
Musunuru, K., Orho-Melander, M., Caulfield, M. P., Li, S., Salameh, W. A., Reitz, R. E., Berglund, G., Hedblad, B., Engström, G., Williams, P. T., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.190405 · Cited by 168
Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk
Damasceno, N. R. T., Sala‐Vila, A., Cofán, M., Pérez-Heras, A., Fitó, M., Ruíz-Gutiérrez, V., Martínez‐González, M. Á., Corella, D., Arós, F., Estruch, R., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.014 · Cited by 166
High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis
Würtz, P., Raiko, J. R. H., Magnussen, C. G., Soininen, P., Kangas, A. J., Tynkkynen, T., Thomson, R. J., Laatikainen, R., Savolainen, M. J., Laurikka, J. O., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs020 · Cited by 158
The composition and metabolism of large and small LDL
Diffenderfer, M. R., & Schaefer, E. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000067 · Cited by 159
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary
Greenland, P., Alpert, J. S., Beller, G., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.002 · Cited by 151
Association of long-term PM2.5 exposure with traditional and novel lipid measures related to cardiovascular disease risk
McGuinn, L. A., Schneider, A. E., McGarrah, R. W., Ward-Caviness, C. K., Neas, L., Di, Q., Schwartz, J. D., Hauser, E. R., Kraus, W. E., Cascio, W. E., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.11.001 · Cited by 140
Physical activity, sedentary behavior time and lipid levels in the Observation of Cardiovascular Risk Factors in Luxembourg study
Crichton, G. E., & Alkerwi, A. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0085-3 · Cited by 111
The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions
Sarzynski, M. A., Burton, J. H., Rankinen, T., Blair, S. N., Church, T. S., Després, J., Hagberg, J. M., Landers‐Ramos, R. Q., Leon, A. S., Mikus, C. R., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.018 · Cited by 99
Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial
Hernáez, Á., Remaley, A. T., Farràs, M., Fernández‐Castillejo, S., Subirana, I., Schröder, H., Fernández-Mampel, M., Muñoz‐Aguayo, D., Sampson, M. L., Solà, R., et al. (2015) · Journal of Nutrition · doi:10.3945/jn.115.211557 · Cited by 97
Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease
Williams, P. T., Zhao, X.-Q., Marcovina, S. M., Otvos, J. D., Brown, B. G., & Krauss, R. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.034 · Cited by 96
Perspective on the health effects of unsaturated fatty acids and commonly consumed plant oils high in unsaturated fat
Petersen, K. S., Maki, K. C., Calder, P. C., Belury, M. A., Messina, M. J., Kirkpatrick, C. F., & Harris, W. S. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524002459 · Cited by 85
Associations of perfluoroalkyl substances (PFAS) with lipid and lipoprotein profiles
Haug, M., Dunder, L., Lind, P., Lind, L., & Salihović, S. (2023) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-023-00545-x · Cited by 84
The effect of periodontal therapy on cardiovascular risk markers: a 6‐month randomized clinical trial
Caúla, A. L., Lira‐Junior, R., Tinoco, E. M. B., & Fischer, R. G. (2014) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12290 · Cited by 84
Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins
Sun, H.-Y., Chen, S.-F., Lai, M.-D., Chang, T., Chen, T.-L., Li, P.-Y., Shieh, D.-B., & Young, K.-C. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.11.023 · Cited by 71
LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study
Pichler, G., Amigó, N., Téllez-Plaza, M., Pardo-Cea, M. Á., Dominguez-Lucas, A., Marrachelli, V. G., Monleón, D., Martı́n-Escudero, J. C., Ascaso, J. F., Chaves, F. J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.128 · Cited by 67
Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?
Fonseca, M. I. H., da Silva, I. T., & Ferreira, S. R. G. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0221-5 · Cited by 68
From Dietary Cholesterol to Blood Cholesterol, Physiological Lipid Fluxes, and Cholesterol Homeostasis
Stellaard, F. (2022) · Nutrients · doi:10.3390/nu14081643 · Cited by 59
Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention
Arca, M., Borghi, C., Pontremoli, R., Ferrari, G. M. D., Colivicchi, F., Desideri, G., & Temporelli, P. L. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.11.001 · Cited by 54
Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women
Ha, L., Shi, Y., Zhao, J., Li, T., & Chen, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126505 · Cited by 52
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk
Rosenson, R. S., Davidson, M. H., & Pourfarzib, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.03.038 · Cited by 51
Dysfunctional HDL in acute stroke
Ortiz-Munoz, G., Couret, D., Lapergue, B., Bruckert, É., Meseguer, E., Amarenco, P., & Meilhac, O. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.035 · Cited by 51
Plant-Based Diets and Lipid, Lipoprotein, and Inflammatory Biomarkers of Cardiovascular Disease: A Review of Observational and Interventional Studies
Elliott, P. S., Kharaty, S. S., & Phillips, C. M. (2022) · Nutrients · doi:10.3390/nu14245371 · Cited by 53
Lipoprotein Subclass Abnormalities and Incident Hypertension in Initially Healthy Women
Paynter, N. P., Sesso, H. D., Conen, D., Otvos, J. D., & Mora, S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.167544 · Cited by 52
New perspectives on CKD-induced dyslipidemia
Bermúdez-López, M., Arroyo, D., Betriu, À., Masana, L., Fernández, E., & Valdivielso, J. M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1369961 · Cited by 50
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study
Pétursson, H., Sigurdsson, J. A., Bengtsson, C., Nilsen, T. I. L., & Getz, L. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2011.01767.x · Cited by 48
Small dense LDL particles - a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study
Toft‐Petersen, A. P., Tilsted, H. H., Aarøe, J., Rasmussen, K., Christensen, T., Griffin, B. A., Aardestrup, I. V., Andreasen, A., & Schmidt, E. B. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-21 · Cited by 47
High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma
Nusinovici, S., Li, H., Thakur, S., Baskaran, M., Tham, Y. C., Zhou, L., Sabanayagam, C., Aung, T., Silver, D. L., Fan, Q., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.09.013 · Cited by 46
High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients
Choi, J., Kim, J. S., Kim, J. H., Oh, K., Koh, S., & Seo, W. (2014) · Neurology · doi:10.1212/wnl.0000000000000264 · Cited by 45
Atherosclerosis — do we know enough already to prevent it?
Narasimhulu, C. A., Fernández-Ruíz, I., Selvarajan, K., Jiang, X., Sengupta, B., Riad, A., & Parthasarathy, S. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.02.006 · Cited by 45
Exploring the Association between Low-Density Lipoprotein Subfractions and Major Adverse Cardiovascular Outcomes—A Comprehensive Review
Stanciulescu, L. A., Scafa‐Udriște, A., & Dorobanţu, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076669 · Cited by 45
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
Ou, J., Xu, Y., Chen, H.-H., Fan, X., Gao, K., Wang, J., Guo, X., Wu, R., & Zhao, J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2850-6 · Cited by 41
A 12-week low-carbohydrate, high-fat diet improves metabolic health outcomes over a control diet in a randomised controlled trial with overweight defence force personnel
Zinn, C., McPhee, J., Harris, N., Williden, M., Prendergast, K. B., & Schofield, G. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0260 · Cited by 43
Longitudinal association between binge eating and metabolic syndrome in adults: Findings from the ELSA‐Brasil cohort
Solmi, F., Moreno, A. B., Lewis, G., Nunes, M. A., da Fonseca, M. D. J. M., & Griep, R. H. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13356 · Cited by 40
Cardiovascular risk factors regulate the expression of vascular endothelin receptors
Xu, C., Sun, Y., & Edvinsson, L. I. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.013 · Cited by 40
Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus
Winkler, K., Jacob, S., Schewe, T., Hoffmann, M. M., & Konrad, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.043 · Cited by 39
Long-term fasting improves lipoprotein-associated atherogenic risk in humans
Grundler, F., Plonné, D., Mesnage, R., Müller, D., Sirtori, C. R., Ruscica, M., & de Toledo, F. W. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02578-0 · Cited by 40
Low-density lipoprotein particle number predicts coronary artery calcification in asymptomatic adults at intermediate risk of cardiovascular disease
Prado, K. B., Shugg, S., & Backstrand, J. R. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.07.001 · Cited by 35
Effect of carbohydrate-restricted dietary interventions on LDL particle size and number in adults in the context of weight loss or weight maintenance: a systematic review and meta-analysis
Falkenhain, K., Roach, L. A., McCreary, S., McArthur, E., Weiss, E. J., François, M. E., & Little, J. P. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab212 · Cited by 36
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects
Mijares, A. H., Ascaso, J. F., Blasco, M., Brea, Á., Díaz, Á., Mantilla, T., Pedro‐Botet, J., Pintó, X., & Millán, J. (2019) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2019.02.002 · Cited by 31
Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: Do novel lipid parameters offer an advantage?
Manickam, P., Rathod, A. D., Panaich, S., Hari, P., Veeranna, V., Badheka, A., Jacob, S., & Afonso, L. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.12.001 · Cited by 31
Triglyceride-Rich Lipoproteins: Their Role in Atherosclerosis
Castillo-Núñez, Y., Morales-Villegas, E., & Aguilar-Salinas, C. A. (2021) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.21000416 · Cited by 35
APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis
Guardiola, M., Cofán, M., de Castro-Orós, I., Cenarro, A., Plana, N., Talmud, P. J., Masana, L., Ros, E., Civeira, F., & Ribalta, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.008 · Cited by 31
Statin Effects on Metabolic Profiles
Kofink, D., Eppinga, R. N., van Gilst, W. H., Bakker, S. J. L., Dullaart, R. P. F., van der Harst, P., & Asselbergs, F. W. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001759 · Cited by 32
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis
Colaco, K., Lee, K., Akhtari, S., Winer, R., Welsh, P. I., Sattar, N. A., McInnes, I. B., Chandran, V., Harvey, P., Cook, R. J., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220168 · Cited by 30
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: Effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size
Tani, S., Matsumoto, M., Nagao, K., & Hirayama, A. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.06.018 · Cited by 30
Regulation of low-density lipoprotein subfractions by carbohydrates
Gerber, P. A., & Berneis, K. K. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283545a6d · Cited by 30
Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
Xu, R., Li, S., Zhang, Y., Li, X., Guo, Y., Zhu, C., & Li, J. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-188 · Cited by 28
Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
Chary, A., Tohidi, M., & Hedayati, M. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03578-0 · Cited by 28
The Role of Non-HDL Cholesterol and Apolipoprotein B in Cardiovascular Disease: A Comprehensive Review
Katsi, V. K., Argyriou, N., Fragoulis, C., & Tsioufis, K. P. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12070256 · Cited by 29
Classification of LDL Phenotypes by 4 Methods of Determining Lipoprotein Particle Size
Sninsky, J. J., Rowland, C. M., Baca, A. M., Caulfield, M. P., & Superko, H. R. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31829d9d17 · Cited by 26
Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL
Mishra, S., Rizvi, A., Pradhan, A. K., Perrone, M. A., & Ali, W. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106536 · Cited by 25
Novel Lipoprotein Subfraction and Size Measurements in Prediction of Mortality in Maintenance Hemodialysis Patients
Noori, N., Caulfield, M. P., Salameh, W. A., Reitz, R. E., Nicholas, S. B., Molnar, M. Z., Nissenson, A. R., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03650411 · Cited by 25
Why Are Some Studies of Cardiovascular Markers Unreliable? The Role of Measurement Variability and What an Aspiring Clinician Scientist Can Do Before It Is Too Late
Shun-Shin, M. J., & Francis, D. P. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.05.006 · Cited by 24
Negatively Cooperative Binding of High-Density Lipoprotein to the HDL Receptor SR-BI
Nieland, T. J. F., Xu, S., Penman, M., & Krieger, M. (2011) · Biochemistry · doi:10.1021/bi101657j · Cited by 23
Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients
Suh, S., Park, H., Kim, S. W., Bae, J. C., Tan, A. H.-K., Chung, H. S., Hur, K. Y., Kim, J. H., Kim, K., & Lee, M. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.536 · Cited by 23
Overview of Risk Factors for Cardiovascular Disease
Rillamas‐Sun, E., Beasley, J. M., Hyde, E. T., & LaCroix, A. Z. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00062-5 · Cited by 22
High disaccharide intake associates with atherogenic lipoprotein profile
Sonestedt, E., Wirfält, E., Wallström, P., Gullberg, B., Drake, I., Hlebowicz, J., Fredrikson, G. N., Hedblad, B., Nilsson, J. Å., Krauss, R. M., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003783 · Cited by 21
Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease
Lin, J., Jain, S., Sun, X., Liu, V., Sato, Y. Z., Jimenez-Fernandez, S., Newfield, R. S., Pourfarzib, R., Tremoulet, A. H., Gordon, J. B., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.06.017 · Cited by 20
Traditional Dietary Recommendations for the Prevention of Cardiovascular Disease: Do They Meet the Needs of Our Patients?
Scholl, J. (2012) · Cholesterol · doi:10.1155/2012/367898 · Cited by 22
Opportunities for Using Lipoprotein Subclass Profile by Nuclear Magnetic Resonance Spectroscopy in Assessing Insulin Resistance and Diabetes Prediction
Wood, A. C., Garvey, W. T., Dall, T., Honigberg, R., & Pourfarzib, R. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0148 · Cited by 19
Replacement of saturated andtrans-fatty acids in the dietv.CVD risk in the light of the most recent studies
Makarewicz‐Wujec, M., Dworakowska, A. M., & Kozłowska−Wojciechowska, M. (2018) · Public Health Nutrition · doi:10.1017/s1368980018000782 · Cited by 19
Metabolic disorders and inflammation are associated with familial combined hyperlipemia
Díaz-Ruiz, M., Martínez-Triguero, M. L., López‐Ruiz, A., la Cruz, F. F.-D., Bañuls, C., & Hernández‐Mijares, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.009 · Cited by 19
Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes
SHAH, A. S., Davidson, W. S., Gao, Z., Dolan, L. M., Kimball, T. R., & Urbina, E. M. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.01.007 · Cited by 17
Keto is Trending: Implications for Body Weight and Lipid Management
Kirkpatrick, C. F., Willard, K.-E., & Maki, K. C. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01731-3 · Cited by 17
Ruminant-Produced trans-Fatty Acids Raise Plasma Total and Small HDL Particle Concentrations in Male Hartley Guinea Pigs ,
Rice, B. H., Kraft, J., Destaillats, F., Bauman, D. E., & Lock, A. L. (2010) · Journal of Nutrition · doi:10.3945/jn.110.127258 · Cited by 17
Intake of Fatty Fish Alters the Size and the Concentration of Lipid Components of HDL Particles and Camelina Sativa Oil Decreases IDL Particle Concentration in Subjects with Impaired Glucose Metabolism
Manninen, S. M., Lankinen, M. A., de Mello, V. D., Laaksonen, D. E., Schwab, U., & Erkkilä, A. T. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201701042 · Cited by 16
CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?
Kjellmo, C. A., Hovland, A., & Lappegård, K. T. (2018) · Diseases · doi:10.3390/diseases6020045 · Cited by 16
The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis
Quesada, J. A., Bertomeu‐González, V., Orozco‐Beltrán, D., Cordero, A., Gil-Guillén, V. F., López‐Pineda, A., Nouni-García, R., & Carratalá‐Munuera, C. (2022) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2022.11.001 · Cited by 16
Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus
Sliem, H. A., Abd-Allha, E., Hassan, B., Abduo, M., & Omar, S. A. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.126585 · Cited by 15
Cardiovascular Disease Risk Factors Other than Dyslipidemia
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17368 · Cited by 16
Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome
Kim, Y., Seo, H. S., Lee, E. M., Na, J. O., Choi, C. U., Lim, H. E., Kim, E. J., Rha, S., Park, C. G., & Oh, D. J. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.86 · Cited by 15
Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial
Demidowich, A. P., Wolska, A. T., Wilson, S. R., Levine, J. A., Sorokin, A. V., Brady, S. M., Remaley, A. T., & Yanovski, J. A. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.10.011 · Cited by 16
Clinical applications of advanced lipoprotein testing in diabetes mellitus
Moin, D. S., & Rohatgi, A. K. (2011) · Clinical Lipidology · doi:10.2217/clp.11.37 · Cited by 15
Lipoprotein Subfractions by Ion Mobility in Lean and Obese Children
Benson, M. R., Hossain, J., Caulfield, M. P., Damaso, L. C., Gidding, S. S., & Mauras, N. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.05.060 · Cited by 14
Pedoman Tatalaksana Dislipidemia PERKI 2013
Erwinanto, E., Santoso, A., Putranto, J. N., Tedjasukmana, P., Suryawan, R., Rifqi, S., & Kasiman, S. (2015) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v34i4.385 · Cited by 14
Cardiometabolic disease risk markers are increased following burn injury in children
Begum, S., Lodge, S., Hall, D., Johnson, B. Z., Bong, S.-H., Whiley, L., Gray, N., Fear, V. S., Fear, M. W., Holmes, E. C., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1105163 · Cited by 14
Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos
Hernández‐Mijares, A., Ascaso, J. F., Blasco, M., Brea, Á., Rodríguez, Á. D., Mantilla, T., Pedro‐Botet, J., Pintó, X., & Millán, J. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.06.007 · Cited by 14
Reduction in dietary trans fat intake is associated with decreased LDL particle number in a primary prevention population
Garshick, M. S., Greenberger, H. M., & Mosca, L. J. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.06.003 · Cited by 13
Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
McGarrah, R. W., Ferencik, M., Giamberardino, S. N., Hoffmann, U., Foldyna, B., Karády, J., Ginsburg, G. S., Kraus, W. E., Douglas, P. S., & Shah, S. H. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026662 · Cited by 12
Associations between serum lipids and glaucoma: a cohort study of 400 229 UK Biobank participants
Ma, Y., Wu, Y., Hu, L., Chen, W., Zhang, X., Zheng, D., Congdon, N. G., Jin, G., & Liu, Z. (2025) · British Journal of Ophthalmology · doi:10.1136/bjo-2024-326062 · Cited by 11

Authors: Ip, S., Lichtenstein, A. H., Chung, M., Lau, J., & Balk, E. M.
Affiliations: Tufts University (US)
Corresponding author: Ip, Stanley
ORCID: Lichtenstein, Alice H.
Chung, Mei
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2009-04-07
Volume: 150
Issue: 7
Pages: 474-484
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-150-7-200904070-00007
PMC: PMC6880859
OpenAlex: W2048908649
Cited by: 163
References: 44
Citations by year: 2026: 5 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 4 · 2019: 9 · 2018: 10 · 2017: 10 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 14 · 2012: 15
FWCI: 2.56
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Public Health Service (290-020022)
National Heart, Lung, and Blood Institute (R01HL054727, R01HL074388)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: low-density lipoprotein subfractions, LDL particle number, cardiovascular risk, cardiovascular outcomes, cardiovascular risk assessment, LDL cholesterol, lipoprotein particle size
MeSH terms: Cardiovascular Diseases, Humans, Lipoproteins, LDL, Risk Factors, Incidence, Disease Progression, Nuclear Magnetic Resonance, Biomolecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks